While most countries prohibit the modification of human embryos using technologies like mitochondrial replacement therapy (MRT) and human germline genome editing, scientists and policymakers are increasingly calling for more relaxed restrictions. These technologies alter one’s germline (the cells that pass on genetic material), providing, proponents say, a way of eliminating […]

Dr. Katherine Drabiak, a USF College of Public Health assistant professor of bioethics and genomics, recently published the article “Emerging Governance of Mitochondrial Replacement Therapy: Assessing Coherence Between Scientific Evidence and Policy Outcomes,” in the DePaul Journal of Health Care Law. Mitochondrial replacement therapy (MRT) is an experimental procedure in […]